| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |